Testing GMDTC for removing excess cadmium
This trial tests an injectable medicine called GMDTC to help remove extra cadmium (a heavy metal) from the body. It is for people with high cadmium levels and decent kidney function, to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- Your urine shows high cadmium levels (more than 5 micrograms for every gram of creatinine).
- Your kidneys work well enough (eGFR 30 or higher on a blood test).
- You do not have poorly controlled diabetes or a serious heart rhythm problem.
- You are not on dialysis and have no known allergies to the study drug ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a continuous glucose monitor (CGM) works in people with diabetes who are also using a special dialysis fluid called icodextrin. The goal is to see if the CGM gives accurate readings while on this treatment.
This study tests how the body handles the drug golcadomide in people with severe kidney problems compared to those with normal kidney function. It aims to understand dosing and safety for patients with kidney impairment.
This study tests if sending reminders to doctors helps improve treatment for chronic kidney disease. It looks at several medicines that can help protect your kidneys.
This trial tests if taking an oral medication to remove lead from the body can slow down kidney function loss in people with type 2 diabetes and kidney disease. It may help if you have higher lead levels in your blood.
This trial tests a special solution (iCM012) that is used to wash and preserve kidneys from older deceased donors (ages 55–75) before they are transplanted. The goal is to see if it helps the kidneys work better after transplant.
This trial tests whether a medicine given through a vein (IV) that binds to lead in your blood can help slow kidney damage in people with type 2 diabetes who also have higher-than-normal lead levels.
Hear when a new Cadmium Exceeds the Standard trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.